Intracavernous Stem Cell Injection for Erectile Dysfunction: Safety and Efficacy Review
Abstract
Background: Erectile dysfunction is a common condition in men characterized by the inability to maintain an erectile state. Current treatment using phosphodiesterase-5 inhibitors treatment may leave significant side effects and effectivity problems in some patients. The use of stem cell transplantation in erectile dysfunction has been emerging as a replacement therapy for erectile dysfunction. The effectiveness of stem cell therapy for the treatment of erectile dysfunction has been investigated in several animal studies and one clinical trial in humans. The intracavernous injection is one of the methods to deliver stem cell treatment for erectile dysfunction besides intravenous and intraperitoneal. It was believed to improve erectile function by promoting cavernosal tissue regeneration, vascularization, and smooth muscle relaxation. However, the intracavernous injection of stem cells for erectile dysfunction treatment in clinical settings requires further investigation since its long-term efficacy and safety concerns regarding swelling, priapism, and fibrous plaque. Objective: This review aims to summarize the available evidence on the safety and efficacy of intracavernous stem cell injection for erectile dysfunction treatment in clinical studies only from PubMed. Conclusion: In conclusion, while the available evidence suggests that intracavernous stem cell injection is considered safe and effective for the treatment of erectile dysfunction, further large-scale clinical studies are needed to determine its long-term safety, efficacy, and optimal dosing regimens.
References
Defeudis G, Mazzilli R, Tenuta M, et al. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metabolism Res. 2022;38(2). doi:10.1002/dmrr.3494
Terentes-Printzios D, Ioakeimidis N, Rokkas K, Vlachopoulos C. Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs. Nat Rev Cardiol. 2022;19(1):59-74. doi:10.1038/s41569-021-00593-6
Mitidieri E, Cirino G, d’Emmanuele Di Villa Bianca R, Sorrentino R. Pharmacology and perspectives in erectile dysfunction in man. Pharmacology & Therapeutics. 2020;208:107493. doi:10.1016/j.pharmthera.2020.107493
Goldstein I, Burnett AL, Rosen RC, Park PW, Stecher VJ. The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction. Sexual Medicine Reviews. 2019;7(1):115-128. doi:10.1016/j.sxmr.2018.06.005
Muncey W, Sellke N, Kim T, Mishra K, Thirumavalavan N, Loeb A. Alternative Treatment for Erectile Dysfunction: a Growing Arsenal in Men’s Health. Curr Urol Rep. 2021;22(2):11. doi:10.1007/s11934-020-01023-9
Matz EL, Terlecki RP. Stem Cell and Gene-Based Therapy for Erectile Dysfunction. Urologic Clinics of North America. 2021;48(4):611-619. doi:10.1016/j.ucl.2021.06.014
Vakalopoulos I, Memmos D, Mykoniatis I, Toutziaris C, Dimitriadis G. Stem cell therapy in erectile dysfunction: science fiction or realistic treatment option? Hormones. 2018;17(3):315-320. doi:10.1007/s42000-018-0050-4
Chen Z, Han X, Ouyang X, Fang J, Huang X, Wei H. Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury. Theranostics. 2019;9(22):6354-6368. doi:10.7150/thno.34008
Park HJ, Jeong H, Park YH, et al. Adipose Tissue-Derived Stem Cell Therapy for Cavernous Nerve Injury-Induced Erectile Dysfunction in the Rat Model: A Systematic Review and Meta-Analysis Using Methodological Quality Assessment. IJSC. 2019;12(2):206-217. doi:10.15283/ijsc18122
Albayrak Ö, Şener TE, Erşahin M, et al. Mesenchymal stem cell therapy improves erectile dysfunction in experimental spinal cord injury. Int J Impot Res. 2020;32(3):308-316. doi:10.1038/s41443-019-0168-1
Yan S, Wang T, Li X, et al. Fabrication of injectable hydrogels based on poly( L -glutamic acid) and chitosan. RSC Adv. 2017;7(28):17005-17019. doi:10.1039/C7RA01864A
Alam MW, Vedaei SS, Wahid KA. A Fluorescence-Based Wireless Capsule Endoscopy System for Detecting Colorectal Cancer. Cancers. 2020;12(4):890. doi:10.3390/cancers12040890
Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem Cells. Journal of Osteopathic Medicine. 2016;116(1):e1-e5. doi:10.7556/jaoa.2016.007
Al Demour S, Jafar H, Adwan S, et al. Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial. Urol Int. 2018;101(3):358-365. doi:10.1159/000492120
Al Demour S, Adwan S, Jafar H, Rahmeh R, Alhawari H, Awidi A. Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical Trial. Urol Int. 2021;105(11-12):935-943. doi:10.1159/000517364
You D, Jang MJ, Song G, et al. Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial. Cytotherapy. 2021;23(10):931-938. doi:10.1016/j.jcyt.2021.06.001
Robles-Torres JI, Mancías-Guerra C, Garza-Bedolla A, Gómez-Guerra LS. Intracavernous application of autologous bone marrow stem cells for medical treatment-refractory erectile dysfunction: A case report. 80.
He L, Yu T, Xiao Y, et al. Co‐overexpression of VEGF and Smad7 improved the therapeutic effects of adipose‐derived stem cells on neurogenic erectile dysfunction in the rat model. Andrologia. 2022;54(10). doi:10.1111/and.14538
Jeon S, Zhu G, Bae W, et al. Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats. IJMS. 2018;19(12):3730. doi:10.3390/ijms19123730
Wang X, Liu C, Xu Y, et al. Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction. Miao D, ed. PLoS ONE. 2017;12(3):e0174145. doi:10.1371/journal.pone.0174145
Towe M, Peta A, Saltzman RG, Balaji N, Chu K, Ramasamy R. The use of combination regenerative therapies for erectile dysfunction: rationale and current status. Int J Impot Res. 2022;34(8):735-738. doi:10.1038/s41443-021-00456-1
Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnology Advances. 2018;36(4):1111-1126. doi:10.1016/j.biotechadv.2018.03.011
Seo B, Yoon S, Do J. Mitochondrial Dynamics in Stem Cells and Differentiation. IJMS. 2018;19(12):3893. doi:10.3390/ijms19123893
Nihad M, Shenoy P S, Bose B. Cell therapy research for Diabetes: Pancreatic β cell differentiation from pluripotent stem cells. Diabetes Research and Clinical Practice. 2021;181:109084. doi:10.1016/j.diabres.2021.109084
Subash S K. Spermatogonial stem cells: A story of self-renewal and differentiation. Front Biosci. 2021;26(1):163-205. doi:10.2741/4891
Hayashi Y, Ohnuma K, Furue MK. Pluripotent Stem Cell Heterogeneity. In: Birbrair A, ed. Stem Cells Heterogeneity - Novel Concepts. Vol 1123. Advances in Experimental Medicine and Biology. Springer International Publishing; 2019:71-94. doi:10.1007/978-3-030-11096-3_6
Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends in Pharmacological Sciences. 2020;41(9):653-664. doi:10.1016/j.tips.2020.06.009
Han Y, Yang J, Fang J, et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Sig Transduct Target Ther. 2022;7(1):92. doi:10.1038/s41392-022-00932-0
Zhuang J, Gao P, Chen H, et al. Extracellular vesicles from human urine‐derived stem cells merged in hyaluronic acid ameliorate erectile dysfunction in type 2 diabetic rats by glans administration. Andrology. 2022;10(8):1673-1686. doi:10.1111/andr.13293
Yang Q, Chen W, Zhang C, et al. Combined Transplantation of Adipose Tissue-Derived Stem Cells and Endothelial Progenitor Cells Improve Diabetic Erectile Dysfunction in a Rat Model. Stem Cells International. 2020;2020:1-15. doi:10.1155/2020/2154053
Mukti A, Ilyas S, Warli S, et al. Umbilical Cord-Derived Mesenchymal Stem Cells Improve TGF-"".ord($0).";""".ord($0).";", “”.ord($0).";""".ord($0).";"-SMA and Collagen on Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats. Med Arch. 2022;76(1):4. doi:10.5455/medarh.2022.76.4-11
Wang J, Mi Y, Wu S, et al. Exosomes from adipose-derived stem cells protect against high glucose-induced erectile dysfunction by delivery of corin in a streptozotocin-induced diabetic rat model. Regenerative Therapy. 2020;14:227-233. doi:10.1016/j.reth.2020.03.002
Chen X, Yang Q, Xie Y, Deng C, Liu G, Zhang X. Comparative study of different transplantation methods of adipose tissue‐derived stem cells in the treatment of erectile dysfunction caused by cavernous nerve injury. Andrologia. 2021;53(4). doi:10.1111/and.13950
Gu X, Thakker PU, Matz EL, et al. Dynamic Changes in Erectile Function and Histological Architecture After Intracorporal Injection of Human Placental Stem Cells in a Pelvic Neurovascular Injury Rat Model. The Journal of Sexual Medicine. 2020;17(3):400-411. doi:10.1016/j.jsxm.2019.12.002
Wang H, Zhang K, Ruan Z, et al. Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway. Stem Cell Res Ther. 2020;11(1):302. doi:10.1186/s13287-020-01788-3
Ti Y, Yang M, Chen X, et al. Comparison of the therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells and adipose-derived stem cells on erectile dysfunction in a rat model of bilateral cavernous nerve injury. Front Bioeng Biotechnol. 2022;10:1019063. doi:10.3389/fbioe.2022.1019063
Yan H, Ding Y, Lu M. Current Status and Prospects in the Treatment of Erectile Dysfunction by Adipose-Derived Stem Cells in the Diabetic Animal Model. Sexual Medicine Reviews. 2020;8(3):486-491. doi:10.1016/j.sxmr.2019.09.006
Matz EL, Thakker PU, Gu X, et al. Administration of secretome from human placental stem cell‐conditioned media improves recovery of erectile function in the pelvic neurovascular injury model. J Tissue Eng Regen Med. 2020;14(10):1394-1402. doi:10.1002/term.3105
Koga S, Horiguchi Y. Efficacy of a cultured conditioned medium of exfoliated deciduous dental pulp stem cells in erectile dysfunction patients. J Cellular Molecular Medi. 2022;26(1):195-201. doi:10.1111/jcmm.17072
Mirzaei M, Bagherinasabsarab M, Pakmanesh H, et al. The Effect of Intracavernosal Injection of Stem Cell in the Treatment of Erectile Dysfunction in Diabetic Patients; A Randomized Single-Blinded Clinical Trial: Stem cell therapy for erectile dysfunction. Urology Journal. 2021;(Instant 2021):6503. doi:10.22037/uj.v18i.6503.
Hermansyah, D.., Putra, A., Munir, D. ., Lelo, A., Amalina, N. D., & Alif, I. . (2021). Synergistic Effect of Curcuma longa Extract in Combination with Phyllanthus niruri Extract in Regulating Annexin A2, Epidermal Growth Factor Receptor, Matrix Metalloproteinases, and Pyruvate Kinase M1/2 Signaling Pathway on Breast Cancer Stem Cell. Open Access Macedonian Journal of Medical Sciences, 9(A), 271–285. https://doi.org/10.3889/oamjms.2021.5941.
Yustianingsih, V., Sumarawati, T., & Putra, A. (2019). Hypoxia enhances self-renewal properties and markers of mesenchymal stem cells. Universa Medicina, 38(3), 164–171. https://doi.org/10.18051/UnivMed.2019.v38.164-171.